DRUGapprovedsmall molecule
mitoxantrone
Approved indications
multiple-sclerosisleukemiacancer
Related claims (1)
| Type | Predicate | Conf | Source |
|---|---|---|---|
| drug target | miR-543, miR-29b, miR-22, miR-200c, and miR-34a have antisense therapeutic potential alone and in combination with Mitoxantrone. | 45% | 40284406 |
Off-Target Findings (0)
No Boltz-2 / Chai-1 off-target panel claims recorded for this drug.